breast cancer
Showing NaN - NaN of 224
Promoting Informed Choice for Breast Cancer Screening: A
Recruiting
- Breast Cancer
- REDS survey
-
Aurora, Colorado
- +1 more
Apr 27, 2023
Breast Cancer, Prostate Cancer Trial in Philadelphia (Standard of Care)
Recruiting
- Breast Cancer
- Prostate Cancer
- Standard of Care
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 22, 2023
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Cancer Trial in Hackensack, Philadelphia, Charlottesville (IORT with CT-Guided HDR Brachytherapy)
Active, not recruiting
- Breast Cancer
- IORT with CT-Guided HDR Brachytherapy
-
Hackensack, New Jersey
- +2 more
Jan 23, 2023
Social Determinants of Cardiotoxicity in Breast Cancer
Recruiting
- Breast Cancer
- +3 more
- Social Determinants of Health
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 19, 2023
Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)
Active, not recruiting
- Breast Cancer
- Breast Neoplasm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jan 17, 2023
Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)
Active, not recruiting
- Breast Cancer
- trastuzumab
- trastuzumab emtansine
-
Anchorage, Alaska
- +275 more
Dec 13, 2022
Breast Cancer Trial in Philadelphia (huCART-meso cells, Mesothelin Expression Testing)
Not yet recruiting
- Breast Cancer
- huCART-meso cells
- Mesothelin Expression Testing
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 5, 2023
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Cancer Gene Mutation, Gastric Cancer, Breast Cancer Trial in Philadelphia (Collection of personal and family history from CAFÉ
Recruiting
- Cancer Gene Mutation
- +2 more
- Collection of personal and family history from CAFÉ Study participants
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 2, 2023
HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)
Completed
- HER2-positive Breast Cancer
- +5 more
-
Tucson, Arizona
- +15 more
Dec 22, 2022
Breast Cancer Trial in Philadelphia (BPET/DBT imaging, 18F-FES)
Not yet recruiting
- Breast Cancer
- BPET/DBT imaging
- 18F-FES
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 12, 2022
Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)
Recruiting
- Breast Cancer
- Non-small Cell Lung Carcinoma
- Trastuzumab deruxtecan (DS-8201a)
- Pembrolizumab
-
San Francisco, California
- +24 more
Nov 30, 2022
Breast Cancer Trial in Philadelphia (Intimacy Enhancement, Living Healthy Together)
Active, not recruiting
- Breast Cancer
- Intimacy Enhancement
- Living Healthy Together
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 1, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer Trial in United States (Photon, Proton)
Recruiting
- Breast Cancer
- Photon
- Proton
-
Birmingham, Alabama
- +40 more
Nov 18, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer, Prostate Cancer, Lung Cancer Trial in New York, Philadelphia (group intervention and questionnaires, individual
Active, not recruiting
- Breast Cancer
- +4 more
- group intervention and questionnaires
- +2 more
-
New York, New York
- +1 more
Oct 3, 2022
Immune Environment in Response to Therapy in Breast Cancer
Recruiting
- Breast Cancer
- +3 more
- Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Sep 15, 2022